STALICLA initiates U.S. Phase 3 enabling DDI study of STP7 (Mavoglurant) to treat cocaine use disorder
May 02, 2024 08:01 ET
|
STALICLA
Geneva, Switzerland, May 2, 2024 – STALICLA SA, a late-stage biotechnology company specializing in precision medicine for brain disorders, announces the First Patient First Visit (FPFV) for the...
Processa Announces Sites Selected for Phase 2B Clinical Trial to Treat Patients with Ulcerated Necrobiosis Lipoidica
March 17, 2021 09:15 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, March 17, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage company developing drugs for patients who have unmet medical...
2020 Encyclopedia of Bone Biology: Coverage of Latest Advances and Hot Topics Including the Hematopoietic Niche and Nuclear Receptors
August 26, 2020 05:32 ET
|
Research and Markets
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Encyclopedia of Bone Biology" book from Elsevier Science and Technology has been added to ResearchAndMarkets.com's offering. The Encyclopedia of...
Evan Leonard, MS, MMS, PA-C is Selected to the American Health Council’s Board of Physicians
August 10, 2018 10:14 ET
|
American Health Council
NEW YORK, Aug. 10, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Evan Leonard, MS, MMS, PA-C to its Board of Physicians for his outstanding contributions to the medical field. An...